| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dc960cc1950195417ca240cafea14fb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
| filingDate |
2014-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02666d21680f37e4ff5bad322f16841c |
| publicationDate |
2014-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014174254-A2 |
| titleOfInvention |
Combination therapy |
| abstract |
The disclosure relates to an agent or agents that inhibit the activity of both, Tumour Necrosis Factor Apoptosis-Inducing Ligand [TRAIL] and osteoprotegerin (OPG) and their use in the treatment of pulmonary hypertension and including agents that bind OPG ligands/receptors |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11168140-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11680101-B2 |
| priorityDate |
2013-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |